
Quick Test To Predict Life Expectancy
The research, published in the European Journal of Preventive Cardiology, evaluated individuals' ability to transition between standing and floor-sitting positions and back up again, without utilising their hands, knees or the support of objects or other people.
Health professionals note that this basic movement serves as a crucial health marker, revealing information about a person's physical state, including flexibility, balance, muscle strength and coordination. These physical qualities show a direct link with heart health and overall cardiovascular function.
The Sitting-Rising Test (SRT) evaluated 4,282 people aged 46 to 75 years (68% men), with scores from 0 to 10 based on performance.
Lower-scoring participants showed higher mortality rates. Middle-aged and older subjects who completed the test independently demonstrated better survival rates.
The study expanded upon previous research examining SRT scores and longevity. The test is scored out of 10 points — 5 for sitting down and 5 for standing up. Begin by crossing one foot in front of the other and lowering yourself to the floor; deduct 1 point for each support used (hand, forearm or knee).
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Air conditioners without external unit. (click to see prices)
Air Condition | Search Ads
Search Now
Undo
Once seated, stand up using the same method of scoring: subtract 1 point for each support and 0.5 points for any loss of balance or wobble.
Throughout a 12-year median observation period, natural causes resulted in 665 deaths, comprising 15.5% of participants. Mortality rates were 3.7% for those scoring 10, rising to 11.1% for scores of 8. The lowest-scoring 10% (0-4) showed a 42.1% mortality rate. After accounting for various factors, those scoring 0-4 showed 3.8 times higher overall mortality risk and 6.0 times higher cardiovascular mortality risk compared to those scoring 10, who could sit and rise from the floor without support or instability.
Researcher Claudio Gil Araújo advised against unsupervised testing. People with physical limitations, including hip or spine injuries, or severe joint conditions, should also avoid this assessment to prevent potential harm.
Dr Niranjan Hiremath, senior cardiovascular consultant and aortic surgeon at Indraprastha Apollo Hospitals, explained, "Poor performance in SRT may indicate reduced cardiovascular reserve, arterial stiffness — an early marker of aging blood vessels — or autonomic nervous system dysfunction, which affects how well the heart adjusts during movement.
This test highlights functional decline that is often invisible in standard check-ups.
Patients may have normal blood pressure or cholesterol levels, but if they lack the physical ability to perform simple movements, their long-term risk for cardiac events may still be high."
Dr Ashish Agarwal, director and head, cardiology, Aakash Healthcare, noted that poor performance might indicate muscle weakness, joint stiffness, coordination issues, or excess weight.
These factors correlate with heart disease, diabetes and chronic conditions.
Emphasising that performance enhancement was achievable through consistent effort, Dr Manish Dhawan, senior consultant, orthopaedics, Sir Gangaram Hospital, recommended stretching routines for legs, hips and lower back to maintain flexibility as well as strength training through squats and chair-rising exercises without hand support to build leg and hip strength.
He advised core exercises, including planks and floor routines, to strengthen back and abdominal muscles and single-leg standing, yoga and gentle exercises are recommended for balance improvement.
Dr Sanjeev Aggarwal, director, cardiac sciences, Sri Balaji Action Medical Institute, stressed the significance of incorporating activities promoting flexibility into everyday routines rather than treating them as sporadic exercise sessions.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
2 hours ago
- Time of India
IISER IAT counselling 2025 registration deadline extended: Check new date and steps to apply here
IISER IAT counselling 2025 registration deadline extended till July 7. The Indian Institutes of Science Education and Research (IISER) have extended the registration deadline for the IAT 2025 counselling process, offering a welcome breather for candidates who qualified through the IISER Aptitude Test. Initially scheduled to close on July 3, 2025, the registration and choice-filling window will now remain open until 5 PM on July 7, 2025. This extension allows eligible students to complete key steps, including submitting documents, filling programme preferences, and paying the counselling fee. Admission through IAT 2025 is for various undergraduate programmes offered across seven IISER campuses located in Berhampur, Bhopal, Kolkata, Mohali, Pune, Thiruvananthapuram, and Tirupati. Who is eligible? Candidates who have qualified the IISER Aptitude Test (IAT) 2025, results for which were declared on June 24, are eligible to participate in the ongoing counselling process. Students are advised to keep their login credentials and all necessary documents ready before proceeding with the registration. How to apply for IISER IAT counselling 2025 ? Eligible candidates can register for IAT counselling process by following the steps given below: Visit the official IISER admission portal : Log in using IAT 2025 credentials Complete the counselling registration form Upload the required documents (Class 10 & 12 marksheets, category certificate, photo ID) Fill in and lock your preferred IISER campuses and programmes Pay the seat acceptance fee Rs. 25,000 for General/OBC-NCL/EWS candidates Rs. 12,500 for SC/ST/PwD candidates Submit the form and take a printout for future reference Seat allotment and further steps After the closure of the registration window on July 7, the first round of seat allotment will be released based on the choices filled and candidate ranks. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like local network access control Esseps Learn More Undo Those allotted a seat will need to accept the offer and pay the confirmation fee to proceed further in the admission process. Further rounds of seat allocation may follow depending on seat availability and candidate withdrawals. IISERs follow a preference-based allocation system, so candidates are advised to carefully fill in their choices in order of priority. Candidates are advised to visit the official website regularly for updates and detailed instructions. Is your child ready for the careers of tomorrow? Enroll now and take advantage of our early bird offer! Spaces are limited.


Time of India
3 hours ago
- Time of India
Agri varsity's makhana discovery secures patent
1 2 Bhagalpur: In a major scientific breakthrough, Bihar Agricultural University (BAU), Bhagalpur, has secured a patent from the govt of India's patent office for the novel identification of a bioactive compound, N-(2-iodophenyl) methanesulfonamide, in Euryale ferox, commonly known as makhana or fox nut. The discovery marks the first time this compound, previously known only as a synthetic pharmacological agent, has been found in a natural source. "It is a major milestone for agricultural innovation and public health and a game-changer for farmers and scientists alike," said BAU vice-chancellor D R Singh. The compound was identified in the perisperm (nutritive tissue) of makhana during extensive research at BAU's NABL-accredited lab. The team included director (research) A K Singh, scientists V Shajeeda Banu, Pritam Ganguly and Anil Kumar, led by VC Singh. The patent was granted on July 2, following BAU's application in December 2024. "Until now, this compound was synthetically produced using complex reactions. Its natural presence in makhana opens new avenues in nutraceuticals and pharmaceuticals," said Singh. The compound has a molecular formula of C₇H₈INO₂S and is being studied for its anti-microbial and anti-cancer potential. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Secure Your Child's Future with Strong English Fluency Planet Spark Learn More Undo "This discovery holds great promise for makhana growers in regions like Mithilanchal and Seemanchal. It could enhance the crop's commercial value, boost agripreneurship, support startup ecosystems and strengthen the global brand of Bihar's GI-tagged makhana," Singh added. Scientist V Shajeeda Banu said, "It is a great achievement for the entire human race."


Time of India
3 hours ago
- Time of India
Healthy lifestyle more beneficial than anti-diabetes drug in long run, study finds
Adopting a healthier lifestyle is more effective than using the anti-diabetes drug metformin, with the benefits persisting over 20 years later, according to a study. The US Diabetes Prevention Program , launched in 1996, enrolled 3,234 patients with prediabetes from 30 institutions across 22 states. The study aimed to compare the benefits of metformin and a lifestyle modification that included exercise and a healthy diet. Researchers from The University of New Mexico , US, found that making lifestyle changes lowered the development of diabetes by 24 per cent, while the anti-diabetes drug lowered it by 17 per cent. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Victoria Principal Is Almost 75, See Her Now Reportingly Undo The findings are published in The Lancet Diabetes and Endocrinology journal . The team noted that differences between the two approaches -- taking metformin and adopting a healthy lifestyle -- were seen in the first few years since the study's start and were durable. Live Events After the first three years, lifestyle interventions, such as weight loss and increased physical activity, led to a 58 per cent reduction in the onset of type 2 diabetes, compared to a 31 per cent reduction with metformin. "The data suggests that those people who didn't get diabetes also didn't get diabetes after 22 years," author Vallabh Raj Shah, professor emeritus at The University of New Mexico's School of Medicine, said. Participants in the lifestyle modification group experienced an additional 3.5 years without diabetes, while those in the metformin group gained an extra 2.5 years. "Within three years (since the study started), they had to stop the study because lifestyle was better than metformin. That means lifestyle, which everybody is banking on, is more effective -- that is the news," Shah added. The authors wrote, "During follow-up, compared with placebo, diabetes incidence rate was reduced in the (intensive lifestyle intervention) group (by 24 per cent), and in the original metformin group (by 17 per cent), with corresponding increases in median diabetes-free survival of 3.5 years and 2.5 years."